← Open Payments lookup

PAUL CARTER: Open Payments

NPI 1639205792 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,537 in 69 payments from 22 companies in 2025. Trend: 2023 $2,291 · 2024 $1,911 · 2025 $1,537

Food & beverage: $1,537
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$179
ABBVIE INC.12$177
Novo Nordisk Inc7$147
Exact Sciences Corporation5$128
Lilly USA, LLC6$125
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$120
GlaxoSmithKline, LLC.3$84
Vanda Pharmaceuticals Inc.2$70
Astellas Pharma US Inc2$68
PFIZER INC.3$56

Products named: Cologuard Collection Kit, MOUNJARO, CAPLYTA, AIRSUPRA, VRAYLAR, TRELEGY ELLIPTA, REXULTI, FANAPT.

Industry payments across PA — which companies pay providers there.